Current Issue: 2025,Vol.33,NO. 02 26
[165-169] Interpretation of Chinese experts' consensus on the whole-course management of implantable venous access port in the upper arm of cancer patients
[ZHOU Can,CHEN Wuke]
2025 02 [Abstract]()
[170-177] DADS down-regulated DJ-1 inhibition of human gastric cancer MGC803 cell invasion and epithelial-mesenchymal transformation via PTEN/Akt pathway
[XIA Hong1,ZHOU Juan1,LIU Fang1,SU Jian2,SU Bo3,SU Qi1]
2025 02 [Abstract]()
[178-185] The expression level and biological function of DRG1 in hepatocellular carcinoma cells
[ZHU Xuanhao1,DANG Yuting1,LI Can2,BIAN Huijie2,LIU Zekun2]
2025 02 [Abstract]()
[186-193] Melatonin increases the sensitivity of esophageal cancer cells to paclitaxel by inhibiting the expression of ESCCAL-1
[ZHANG Jing,ZHANG Yueli,GUAN Hongya,LIU Jia]
2025 02 [Abstract]()
[194-198] Preliminary study on the effect of intratumoral gram-negative bacteria on lung cancer cell death
[ZHANG Huijie1，ZHAI Meng'en2，JIANG Jianli3，JING Lin3]
2025 02 [Abstract]()
[199-207] The expression of circular RNA circPRELID2 with coding function in colorectal cancer tissues and its effects on cell proliferation and apoptosis
[SHENG Huan1,FU Dandan1,HU Xiaoyun1,2,FAN Yuxuan1,WANG Ziqing1,ZHANG Mingrong1,WU Ting1,ZHANG Yongzhen1,SUN Huimin1,WU Huizhe1,2]
2025 02 [Abstract]()
[208-217] Effect of exosomal circ-0001328 on gemcitabine resistance in gallbladder cancer cells by targeting miR-545-3p
[CHEN Ping1,WU Jianchun1,YANG Zhen2,JIANG Shihao2,ZHOU Ning2]
2025 02 [Abstract]()
[218-225] Expression levels of serum VEGF-A and EFNA1 in patients with papillary thyroid carcinoma and their correlation with cervical lymph node metastasis
[WANG Chun1,ZHANG Linlin2,ZHAO Hongjian2,XING Hao3,YIN Fengyan3,ZHANG Hui3,CAO Wenyuan1,LUO Xiaoting1,HE Qian1,XING Weijia1]
2025 02 [Abstract]()
[226-233] Correlation between tertiary lymphoid structures scores and class-switched memory B cells in breast cancer microenvironment and its effect on patients survival
[ZHU Liangxiao1，DU Yiqiao2，WANG Wenhui2，JIANG Guangjie3，ZHANG Chao4,GAO Fenghou1]
2025 02 [Abstract]()
[234-240] Expression and significance of LncRNA Linc01305 from plasma extracellular vesicles in breast cancer
[LIANG Li1,SHEN Jian2,PENG Huiyong3，ZHANG Lei1,ZHU Dongwei2]
2025 02 [Abstract]()
[241-248] Nutritional and inflammatory markers for predicting acute severe adverse events in patients with esophageal squamous cell carcinoma treated by radical radiotherapy and concurrent chemoradiotherapy
[DENG Jie,YANG Bo,SUN Xiang]
2025 02 [Abstract]()
[249-254] Single hole thoracoscopic lobectomy in the treatment of lung cancer patients converted to thoracotomy:Influencing factors
[FAN Yisong,WANG Rui]
2025 02 [Abstract]()
[255-262] The role of kappa/lambda light chain ratio in evaluating the efficacy of bortezomib in the treatment of patients with multiple myeloma
[YANG Juanjuan,LI Xiaotong,DAI Suya]
2025 02 [Abstract]()
[263-268] Risk factors related to the death of patients with diffuse large B-cell lymphoma within one year and the construction of prediction model
[LI Nana1，DING Binbin1，DONG Bai1，LI Zijian2]
2025 02 [Abstract]()
[269-274] Analysis of clinicopathological features and prognostic factors in 5 cases of primary ovarian goiter carcinoid
[WEI Xin1，ZHANG Yanrui1,LU Xiangyu1，LIU Limin2]
2025 02 [Abstract]()
[275-280] Analysis of the effect of PD-1 inhibitor treatment on blood cell immune factors in patients with cervical malignancies
[WEI Yongqiang,YANG Zhijun,ZHAO Bingbing,LI Zhuang,ZHOU Lu,LI Kuina,YANG Meng,HUANG Zhijiong]
2025 02 [Abstract]()
[281-287] Effect of propofol and remimazolam benzenesulfonate on intracranial pressure and quality of postoperative awakening in patients underwent laparoscopy surgeries with gynecological tumors
[LENG Lin1，JIN Yeyuan2，HE Zongzhao2，ZHANG Lingmin3，LI Fugui2]
2025 02 [Abstract]()
[288-292] A radiomics model based on multi-phase contrast-enhanced CT for predicting HER2 expression in gastric cancer patients
[SONG Tianjun1，2,XUE Bing3,HU Chunfeng2，4]
2025 02 [Abstract]()
[298-302] Research progress and future perspectives of gut microbiota in endocrine therapy for hormone receptor-positive breast cancer
[YAO Peizhuo,FANG Biyun,LI Chaofan,JIA Yiwei,WEI Xinyu,ZHANG Shuqun]
2025 02 [Abstract]()
[303-310] Research progress on neoadjuvant immunotherapy for locally advanced head and neck squamous cell carcinoma
[PU Shasha1,2,HU Yunfeng3,SHI Mei2]
2025 02 [Abstract]()
[311-315] Research progress of magnetic resonance imaging radiomics in the diagnosis and treatment of rectal cancer
[SU Yexin1，ZHAO Hongyue2，LIU Pengfei1]
2025 02 [Abstract]()
[316-320] Research progress of immunotherapy for microsatellite instability gastric cancer
[ZHANG Xin1,FANG Changxing2,YANG Min3,YAO Tian4,JIA Kai4,GUO Jiansheng4]
2025 02 [Abstract]()
[321-326] Research progress of CRISPR/Cas9 technology in endometrial cancer treatment
[NIU Yimo，WANG Yuning,ZHANG Yi]
2025 02 [Abstract]()
[327-334] Advances of artificial intelligence in histological diagnosis of colorectal cancer and its precancerous lesions
[WU Zhifeng1,2,3,YAO Liwen1,2,3,WU Lianlian1,2,3,ZENG Zhi4,YU Honggang1,2,3]
2025 02 [Abstract]()
[335-341] Key advances in anatomy and resection techniques of the caudate lobe of the liver
[WANG Yunfeng1,WU Xiaobing2,JIANG Xiaoqing2]
2025 02 [Abstract]()
[342-348] Research progress of PANoptosis in tumor treatment
[ZHENG Shuting1，LI Shanshan1，DU Xinyi1，FU Bo2]
2025 02 [Abstract]()